Intestinal microbiota and biliary system diseases
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1362933 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Hua Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Biliary Tract Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The incidence of biliary system diseases has been continuously increasing in the past decade. Biliary system diseases bring a heavy burden to humanity and society. However, the specific etiology and pathogenesis are still unknown. The biliary system, as a bridge between the liver and intestine, plays an indispensable role in maintaining the physiological metabolism of the body. Therefore, prevention and treatment of biliary diseases are crucial. It is worth noting that the microorganisms participate in the lipid metabolism of the bile duct, especially the largest proportion of intestinal bacteria.
Methods
We systematically reviewed the intestinal microbiota in patients with gallstones (GS), non-calculous biliary inflammatory, and biliary tract cancer (BTC). And searched Pubmed, Embase and Web of science for research studies published up to November 2023.
Results
We found that the abundance of Faecalibacterium genus is decreased in GS, primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and BTC. Veillonella, Lactobacillus, Streptococcus and Enterococcus genus were significantly increased in PSC, PBC and BTC. Interestingly, we found that the relative abundance of Clostridium was generally reduced in GS, PBC and BTC. However, Clostridium was generally increased in PSC.
Discussion
The existing research mostly focuses on exploring the mechanisms of bacteria targeting a single disease. Lacking comparison of multiple diseases and changes in bacteria during the disease process. We hope to provide biomarkers forearly diagnosis of biliary system diseases and provide new directions for the mechanism of intestinal microbiota in biliary diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China.
- Department of General Surgery, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China.
- Department of Pharmacy, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China.
Zitieren
APA
Wang, H., Gong, J., Chen, J., Zhang, W., Sun, Y., & Sun, D. (2024). Intestinal microbiota and biliary system diseases. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1362933
Vancouver
Wang H, Gong J, Chen J, Zhang W, Sun Y, Sun D. Intestinal microbiota and biliary system diseases. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1362933
BibTeX
@article{Wang2024,
author = {Wang, Hua and Gong, Junfeng and Chen, Jingyi and Zhang, Wei and Sun, Yanjun and Sun, Dengqun},
title = {Intestinal microbiota and biliary system diseases},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1362933}
}
EUVIMED